Freenome Revenue and Competitors

Claim your profile

Location

#3483

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Freenome's estimated annual revenue is currently $111.5M per year.(i)
  • Freenome received $7.0M in venture funding in August 2017.
  • Freenome's estimated revenue per employee is $217,000
  • Freenome's total funding is $1.1B.

Employee Data

  • Freenome has 514 Employees.(i)
  • Freenome grew their employee count by 44% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$300.8M121334%$2B$2.5B
#2
$7.3M60-19%$27.2MN/A
#3
$9.3M43N/AN/AN/A
#4
$1M12N/AN/AN/A
#5
$3.3M40N/AN/AN/A
#6
$23.9M150N/AN/AN/A
#7
$20M12928%$1.4MN/A
#8
$132.3M106029%$503.1M$3B
#9
$2.7M23N/AN/AN/A
#10
$2.7M27N/AN/AN/A
#11
$69.3M396N/AN/AN/A
#12
$7.3M29N/AN/AN/A
#13
$1082.8M4314N/AN/AN/A
#14
$95.6M312N/AN/AN/A

Freenome is an AI genomics company on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent their diseases. By applying advanced machine learning techniques to recent breakthroughs in genomic science, Freenome is developing noninvasive blood tests to detect early-stage cancer and improve precision oncology treatments for patients everywhere. The company has raised $78 million from investors such as Andreessen Horowitz, Google Ventures, Polaris Partners, and Founders Fund. More information at: https://www.freenome.com/ For those who crave challenges, understudied problems, and the chance to see their work impact millions of lives touched by cancer, there's no better place to be. Ready to join the fight Search available positions and get in touch at: https://www.freenome.com/careers

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals

$1.1B

Total Funding

514

Number of Employees

$111.5M

Revenue (est)

44%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Freenome News

2022-04-20 - AI Medicine Software Market Size, Outlook And Forecast ...

... Atomwise, DeepMind, Babylon Health, Flatiron Health, Tempus Labs, Sophia Genetics, Recursion Pharmaceuticals, Synyi, Freenome.

2022-03-30 - LANCE BALDO JOINS FREENOME AS CHIEF MEDICAL ...

Freenome is a biotechnology company with a comprehensive multiomics platform for the detection of cancer using a routine blood draw. The company...

2022-03-22 - Freenome's big lease highlights life science demand - San ...

Cancer diagnostics company Freenome Inc. signed a lease for more than half of the space available at the waterfront biotech campus known as...

2021-05-21 - Freenome, high-profile liquid biopsy company, quietly replaces its CEO

Freenome, a high-profile startup that aims to develop a blood test to detect colon cancer, has quietly replaced its co-founder and chief executive, Gabriel Otte. The company’s chief business officer, Mike Nolan, a long-time veteran of the genomics and diagnostic industries, is Freenome’s new CE ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$192.9M53210%N/A
#2
$135.8M62624%$681.3M
#3
$12.8M660-7%$59.3M
#4
$179.9M66720%$532.5M
#5
$106.8M7634%N/A

Freenome Funding

DateAmountRoundLead InvestorsReference
2016-06-10$5.6MUndisclosedMultipleArticle
2017-03-02$65.0MAAndreessen HorowitArticle
2017-08-29$7.0MASection 32Article